Attacking pain at its source: New perspectives on opioids

Nature Medicine

Volumn 9, Issue 8, 2003, Pages 1003-1008

  Stein, Christoph ^a   Schäfer, Michael ^a   Machelska, Halina ^a  

^a FREIE UNIVERSITÄT BERLIN   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ACETAMIDE DERIVATIVE; ANALGESIC AGENT; ASIMADOLINE; BRAIN RECEPTOR; CELL ADHESION MOLECULE; DELTA OPIATE RECEPTOR AGONIST; DEXAMETHASONE; DYNORPHIN; ENDORPHIN; ENKEPHALIN; FENTANYL; KAPPA OPIATE RECEPTOR AGONIST; LOPERAMIDE; MORPHINE; MU OPIATE RECEPTOR AGONIST; NALOXONE; OPIATE; OPIATE AGONIST; OPIATE RECEPTOR; SUFENTANIL;

ANALGESIA; ANTIINFLAMMATORY ACTIVITY; CELL MIGRATION; CENTRAL NERVOUS SYSTEM; CLINICAL TRIAL; DRUG ADMINISTRATION; DRUG EFFECT; DRUG EFFICACY; DRUG TOLERANCE; HUMAN; IMMUNOCOMPETENT CELL; NONHUMAN; PAIN; PERIPHERAL NERVOUS SYSTEM; PLANTARIS MUSCLE; PRIORITY JOURNAL; REVIEW; SENSORY NERVE CELL; SIGNAL TRANSDUCTION; TISSUE INJURY;

ANALGESICS, OPIOID; ANIMALS; CELL MOVEMENT; DRUG TOLERANCE; HUMANS; LIGANDS; NEURONS, AFFERENT; OPIOID PEPTIDES; PAIN; RECEPTORS, OPIOID; SIGNAL TRANSDUCTION;

EID: 0041965945     PISSN: 10788956     EISSN: None     Source Type: Journal    
DOI: 10.1038/nm908     Document Type: Review

References (103)

1. Kietter, B. L & Gaveriaux-Ruff, C. Exploring the opioid system by gene knockout. Prog. Neurobiol. 66, 285-306 (2002).
2. Brower, V. New paths to pain relief. Nat. Biotechnol. 18, 387-391 (2000).
3. Machelska, H. & Stein, C. Immune mechanisms in pain control. Anesth. Analg. 95, 1002-1008 (2002).
4. Pan, Z.Z. Mu-opposing actions of the kappa-oploid receptor. Trends Pharmacol. Sci. 19, 94-98 (1998).
5. Stein, C., Machelska, H & Schäfer, M. Peripheral analgesic and antiinflammatory effects of opioids. Z. Rheumatol. 60, 416-424 (2001).
6. Fields, H.L., Emson, P.C., Leigh, B.K., Gilbert, R.F.T. & Iversen, L.L. Multiple opiate receptor sites on primary afferent fibres. Nature 284, 351-353 (1980).
7. Young, I., W.S., Wamsley, J.K., Zarbin, M.A. & Kuhar, M.J. Opioid receptors undergo axonal flow. Science 210, 76-77 (1980).
8. Hassan, A.H.S., Ableitner. A., Stein, C. & Herz, A. Inflammation of the rat paw enhances axonal transport of opioid receptors in the sciatic nerve and increases their density in the inflamed tissue. Neuroscience 55, 185-195 (1993).
9. Mousa, S.A., Zhang, Q., Sitte, N., Ji, R. & Stein, C. Beta-endorphin-containing memory-cells and mu-opioid receptors undergo transport to peripheral inflamed tissue. J. Neuroimmunol. 115, 71-78 (2001)
10. Truong, W., Cheng, C., Xu, Q.G., Li, X.Q. & Zochodne, D.W. Mu opioid receptors and analgesia at the site of a peripheral nerve injury. Ann. Neurol. 53, 366-375 (2003).
11. Stein, C. et al. Opioids from immunocytes interact with receptors on sensory nerves to inhibit nociception in inflammation. Proc. Natl. Acad. Sci. USA 87, 5935-5939 (1990).
12. Coggeshall, R.E., Zhou, S & Carlton, S.M. Opiate receptors on peripheral sensory axons. Brain Res. 764, 126-132 (1997).
13. Wenk, H.N. & Honda, C.N. Immunchistochemical localization of delta opioid receptors in peripheral tissues. J. Comp. Neurol. 408, 567-579 (1999).
14. Stein, C. et al. No tolerance to peripheral morphine analgesia in presence of opioid expression in inflamed synovia. J. Clin. Invest. 98, 793-799 (1996).
15. Pare, M., Elde, R., Mazurkiewicz, J.E., Smith, A.M. & Rice, F.L. The Meissner corpuscle revised: a multiafferented mechanoreceptor with nociceptor immunochemical properties. J. Neurosci. 21, 7236-7246 (2001)
16. Poonyachoti, S., Kulkarni-Narla, A. & Brown, D.R. Chemical coding of neurons expressing delta- and kappa-opioid receptor and type I vanilloid receptor immunoreactivities in the porcine ileum. Cell Tissue Res. 307, 23-33 (2002).
17. Minami, M., Maekawa, K., Yabuuchi, K. & Satoh, M. Double in situ hybridization study on coexistence of mu-, delta- and kappa-opioid receptor mRNAs with preprotachykinin A mRNA in the rat dorsal root ganglia. Brain Res. Mol. Brain Res. 30, 203-210 (1995).
18. Borgland, S.L., Connor, M. & Christie, M.J. Nociceptin inhibits calcium channel currents in a subpopulation of small nociceptive trigeminal ganglion neurons in mouse. J. Physiol. 536, 35-47 (2001).
19. Zhou, L., Zhang, Q., Stein, C. & Schäfer, M. Contribution of opioid receptors on primary afferent versus sympathetic neurons to peripheral opioid analgesia. J. Pharmacol, Exp. Ther. 286, 1000-1006 (1998).
20. Pertovaara, A. & Wei, H. Peripheral effects of morphine in neuropathic rats: role of sympathetic postganglionic nerve fibers. Eur. J. Pharmacol 429, 139-145 (2001).
21. Zöllner, C. et al. Painful inflammation-induced increase in mu-opioid receptor binding and G-protein coupling in primary afferent neurons. Mol. Pharmacol. (in the press).
22. Lewanowitsch, T. & Irvine, R.J. Naloxone methiodide reverses opioid-induced respiratory depression and analgesia without withdrawal. Eur. J. Pharmacol. 445, 61-67 (2002).
23. Shannon, H.E. & Lutz, E.A. Comparison of the peripheral and central effects of the opioid agonists loperamide and morphine in the formalin test in rats. Neuropharmacol. 42, 253-261 (2002).
24. King, M., Su, W., Chang, A., Zuckerman, A. & Pasternak, G.W. Transport of opioids from the brain to the periphery by P-glycoprotein: peripheral actions of central drugs. Nat. Neurosci. 4, 268-274 (2001).
25. Jiang, M. et al. Multiple neurological abnormalities in mice deficient in the G protein Go, Proc. Natl. Acad. Sci. USA 95, 3269-3274 (1998).
26. Taddese, A., Nah, S.-Y. & McCleskey, E.W. Selective opioid inhibition of small nociceptive neurons. Science 270, 1366-1369 (1995).
27. Akins, P.T. & McCleskey, E.W. Characterization of potassium currents in adult rat sensory neurons and modulation by opioids and cyclic AMP. Neuroscience 56, 759-769 (1993).
28. Ingram, S.L. & Williams, J.T. Opioid inhibition of Ih via adenylyl cyclase. Neuron 13, 179-186 (1994).
29. + current in rat sensory neurons in vitro. Neurosci. Lett. 212, 83-86 (1996).
30. Laird, J.M., Souslova, V., Wood, J.N. & Cervero, F. Deficits in visceral pain and referred hyperalgesia in Nav1.8 (SNS/PN3)-null mice. J. Neurosci. 22, 8352-8356 (2002).
31. Porreca, F. et al. A comparison of the potential role of the tetrodotoxin-insensitive sodium channels, PN3/SNS and NaN/SNS2, in rat models of chronic pain. Proc. Natl. Acad. Sci. USA 96, 7640-7644 (1999).
32. Stein, C. Peripheral mechanisms of opioid analgesia. Anesth Analg. 76, 182-191 (1993).
33. Walker, J., Catheline, G., Guilbaud, G. & Kayser, V. Lack of cross-tolerance between the antinociceptive effects of systemic morphine and asimadoline, a peripherally-selective kappa-opioid agonist, in CCl-neuropathic rats. Pain 83, 509-516 (1999).
34. Kalso, E., Smith, L., McQuay, H.J & Moore, R.A. No pain, no gain: clinical excellence and scientific rigour - lessons learned from IA morphine, Pain 98, 269-275 (2002).
35. Kraus, J et al. Regulation of mu-opioid receptor gene transcription by interleukin-4 and influence of an allelic variation within a STAT6 transcription factor binding site. J. Biol. Chem. 276, 43901-43908 (2001).
36. Borner, C., Höllt, V. & Kraus, J. Involvement of activator protein-1 in transcriptional regulation of the human mu-opioid receptor gene. Mol. Pharmacol. 61, 800-805 (2002).
37. Ji, R.-R. et al. Expression of μ-, δ-, and κ-opioid receptor-like immunoreactivities in rat dorsal root ganglia after carrageenan-induced inflammation. J. Neurosci. 15, 8156-8166 (1995).
38. Jeanjean, A.P., Moussacui, S.M., Maloteaux, J.-M. & Laduron, P.M. Interleukin-1β induces long-term increase of axonally transported opiate receptors and substance P, Neuroscience 68, 151-157 (1995).
39. Selley, D.E., Breivogel, C.S. & Childers, S.R. Modification of G protein-coupled functions by low pH pretreatment of membranes from NG108-15 cells: increase in opioid agonist efficacy by decreased inactivation of G proteins. Mol. Pharmacol. 44, 731-741 (1993).
40. Antonijevic, I., Mousa, S.A., Schäfer, M. & Stein, C. Perineurial defect and peripheral opioid analgesia in inflammation. J. Neurosci. 15, 165-172 (1995).
41. Picard, P.R., Tramer, M.R., McQuay, H.J. & Moore, R.A. Analgesic efficacy of peripheral opioids (all except intra-articular): a qualitative systematic review of randomised controlled trials. Pain 72, 309-318 (1997).
42. Murphy, D.B., McCartney, C.J. & Chan, V.W. Novel analgesic adjuncts for brachial plexus block: a systematic review. Anesth. Analg. 90, 1122-1128 (2000).
43. Schulte-Steinberg, H. et al. Intraperitoneal versus interpleural morphine or bupivacaine for pain after laparoscopic cholecystectomy. Anesthesiology 82, 634-640 (1995).
44. Likar, R. et al. Efficacy of peripheral morphine analgesia in inflamed, non-inflamed and perineural tissue of dental surgery patients. J. Pain Symptom Manage. 21, 330-337 (2001).
45. Aley, K.O., Green, P.G. & Levine, J.D. Opioid and adenosine peripheral antinociception are subject to tolerance and withdrawal. J. Neurosci. 15, 8031-8038 (1995).
46. Kolesnikov, Y. & Pasternak, G.W. Topical opioids in mice: analgesia and reversal of tolerance by a topical N-methyl-D-aspartate antagonist. J. Pharmacol. Exp. Ther. 290, 247-252 (1999).
47. Honore, P., Catheline, G., Le Guen, S. & Besson, J.M. Chronic treatment with systemic morphine induced tolerance to the systemic and peripheral antinociceptive effects of morphine on both carrageenin induced mechanical hyperalgesia and spinal c-Fos expression in awake rats. Pain 71, 99-108 (1997).
48. Nozaki-Taguchi, N. & Yaksh, T.L. Characterization of the antihyperalgesic action of a novel peripheral mu-opioid receptor agonist-loperamide. Anesthesiology 90, 225-234 (1999).
49. Ferreira, S.H., Lorenzetti, B.B. & Rae, G.A. Is methylnalorphinium the prototype of an ideal peripheral analgesic. Eur. J. Pharmacol. 99, 23-29 (1984).
50. Ueda, H. & Inoue, M. Peripheral morphine analgesia resistant to tolerance in chronic morphine-treated mice. Neurosci. Lett. 266, 105-108 (1999).
51. Kieffer, B.L. & Evans, C.J. Opioid tolerance - in search of the holy grail. Cell 108, 587-590 (2002).
52. Smith, E.M. Opioid peptides in immune cells. Adv. Exp. Med. Biol. 521, 51-68 (2003).
53. Cabot, P.J. et al. Immune cell-derived β-endorphin: production, release and control of inflammatory pain in rats. J. Clin. Invest. 100, 142-148 (1997).
54. Cabot, P.J., Carter, L., Schäfer, M. & Stein, C. Methionine-enkephalin- and Dynorphin A-release from immune cells and control of inflammatory pain. Pain 93, 207-212 (2001).
55. Stein, C., Hassan, A.H.S., Lehrberger, K., Giefing, J. & Yassouridis, A. Local analgesic effect of endogenous opioid peptides. Lancet 342, 321-324 (1993).
56. Rittner, H.L. et al. Opioid peptide-expressing leukocytes: identification, recruitment, and simultaneously increasing inhibition of inflammatory pain. Anesthesiology 95, 500-508 (2001).
57. Mousa, S.A., Machelska, H., Schäfer, M. & Stein, C. Immunohistochemical localization of endomorphin-1 and endomorphin-2 in immune cells and spinal cord in a model of inflammatory pain. J. Neuroimmunol. 126, 5-15 (2002).
58. von Andrian, U.H. & Mackay, C.R. T-cell function and migration. Two sides of the same coin. N. Engl. J. Med. 343, 1020-1034 (2000).
59. Mousa, S.A., Machelska, H., Schäfer, M. & Stein, C. Co-expression of beta-endorphin with adhesion molecules in a model of inflammatory pain. J. Neuroimmunol. 108, 160-170 (2000).
60. Machelska, H. et al. Opioid control of inflammatory pain regulated by intercellular adhesion molecule-1. J. Neurosci. 22, 5588-5596 (2002).
61. Machelska, H., Cabot, P.J., Mousa, S.A., Zhang, Q. & Stein, C. Pain control in inflammation governed by selectins. Nat. Med. 4, 1425-1428 (1998).
62. Schäfer, M., Carter, L. & Stein, C. Interleukin-1β and corticotropin-releasing-factor inhibit pain by releasing opioids from immune cells in inflamed tissue. Proc. Natl. Acad. Sci. USA 91, 4219-4223 (1994).
63. Schäfer, M., Mousa, S.A., Zhang, Q., Carter, L. & Stein, C. Expression of corticotropin-releasing factor in inflamed tissue is required for intrinsic peripheral opioid analgesia. Proc. Natl. Acad. Sci. USA 93, 6096-6100 (1996).
64. Schmitt, T.K. et al. Modulation of peripheral endogenous opioid analgesia by central afferent blockade. Anesthesiology 98, 195-202 (2003).
65. Parsons, C.G., Czlonkowski, A., Stein, C. & Herz, A. Peripheral opioid receptors mediating antinociception in inflammation. Activation by endogenous opioids and role of the pituitary-adrenal axis. Pain 41, 81-93 (1990).
66. Khoderova, A. et al. Endothelin-B receptor activation triggers an endogenous analgesic cascade at sites of peripheral injury. Nat. Med. 9, 1055-1061 (2003).
67. Braz, J. et al. Therapeutic efficacy in experimental polyarthritis of viral-driven enkephalin overproduction in sensory neurons. J. Neurosci. 21, 7881-7888 (2001).
68. Barber, A et al. A pharmacological profile of the novel, peripherally-selective κ-opioid receptor agonist, EMD 61753. Br. J. Pharmacol. 113, 1317-1327 (1994).
69. Jonker, J.W. et al. Role of blood-brain barrier P-glycoprotein in limiting brain accumulation and sedative side-effects of asimadoline, a peripherally acting analgaesic drug. Br. J. Pharmacol. 127, 43-50 (1999).
70. DeHaven-Hudkins, D.L. et al. Loperamide (ADL 2-1294), an opioid antihyperalgesic agent with peripheral selectivity. J. Pharmacol. Exp. Ther. 289, 494-502 (1999).
71. Sandner-Kiesling, A. et al. Effect of kappa opioid agonists on visceral nociception induced by uterine cervical distension in rats. Pain 96, 13-22 (2002).
72. Eisenach, J.C., Carpenter, R. & Curry, R. Analgesia from a peripherally active κ-opioid receptor agonist in patients with chronic pancreatitis. Pain 101, 89-95 (2003).
73. Binder, W. et al. Analgesic and antiinflammatory effects of two novel kappa opioid peptides. Anesthesiology 94, 1034-1044 (2001).
74. Stein, C., Millan, M.J., Shippenberg, T.S., Peter, K. & Herz, A. Peripheral opioid receptors mediating antinociception in inflammation. Evidence for involvement of mu, delta and kappa receptors. J. Pharmacol. Exp. Ther. 248, 1269-1275 (1989).
75. Machelska, H. et al. Peripheral effects of the kappa-opioid agonist EMD 61753 on pain and inflammation in rats and humans. J. Pharmacol. Exp. Ther. 290, 354-361 (1999).
76. Averbeck, B., Reeh, P.W. & Michaelis, M. Modulation of CGRP and PGE2 release from isolated rat skin by alpha-adrenoceptors and kappa-opioid-receptors. Neuroreport 12, 2097-2100 (2001).
77. Yaksh, T.L. Substance P release from knee joint afferent terminals: modulation by opioids. Brain Res. 458, 319-324 (1988).
78. Chao, C.C., Molitor, T.W., Close, K., Hu, S. & Peterson, P.K. Morphine inhibits the release of tumor necrosis factor in human peripheral blood mononuclear cell cultures. Int J. Immunopharmacol. 15, 447-453 (1993).
79. Wilson, J.L., Walker, J.S., Antoon, J.S. & Perry, M.A. Intercellular adhesion molecule-1 expression in adjuvant arthritis in rats: inhibition by kappa-opioid agonist but not by NSAID. J. Rheumatol. 25, 499-505 (1998).
80. Sengupta, J.N., Snider, A., Su, X. & Gebhart, G.F. Effects of kappa opioids in the inflamed rat colon. Pain 79, 175-185 (1999).
81. Houghton, A.K., Valdez, J.G. & Westlund, K.N. Peripheral morphine administration blocks the development of hyperalgesia and allodynia after bone damage in the rat. Anesthesiology 89, 190-201 (1998).
82. Likar, R. et al. Intraarticular morphine analgesia in chronic pain patients with osteoarthritis. Anesth. Analg. 84, 1313-1317 (1997).
83. Stein, A., Yassouridis, A., Szopko, C., Helmke, K. & Stein, C. Intraarticular morphine versus dexamethasone in chronic arthritis. Pain 83, 525-532 (1999).
84. Khoury, G.F., Chen, A.C.N., Garland, D.E. & Stein, C. Intraarticular morphine, bupivacaine and morphine/bupivacaine for pain control after knee videoarthroscopy. Anesthesiology 77, 263-266 (1992).
85. Reuben, S.S. et al. Local administration of morphine for analgesia after iliac bone graft harvest. Anesthesiology 95, 390-394 (2001).
86. Peyman, G.A., Rahimy, M.H. & Fernandes, M.L. Effects of morphine on corneal sensitivity and epithelial wound healing: implications for topical ophthalmic analgesia. Br. J. Ophthalmol. 78, 138-141 (1994).
87. Duckett, J.W., Cangiano, T., Cubina, M., Howe, C. & Cohen, D. Intravesical morphine analgesia after bladder surgery. J. Urol. 157, 1407-1409 (1997).
88. Rorarius, M. et al. Peripherally administered sufentanil inhibits pain perception after postpartum tubal ligation. Pain 79, 83-88 (1999).
89. Rosseland, L.A., Stubhaug, A., Skoglund, A. & Breivik, H. Intra-articular morphine for pain relief after knee arthroscopy. Acta Anaesthesiol. Scand. 43, 252-257 (1999).
90. Bickel, A. et al. Effects of antihyperalgesic drugs on experimentally induced hyperalgesia in man. Pain 76, 317-325 (1998).
91. Polydefkis, M. et al. Reduced intraepidermal nerve fiber density in HIV-associated sensory neuropathy. Neurology 58, 115-119 (2002).
92. Lu, C.Y. et al. Gene-gun particle with pro-opiomelanocortin cDNA produces analgesia against formalin-induced pain in rats. Gene Ther. 9, 1008-1014 (2002).
93. Taguchi, A. et al. Selective postoperative inhibition of gastrointestinal opioid receptors. N. Engl. J. Med. 345, 935-940 (2001).
94. Simonin, F. & Kieffer, B.L. Two faces for an opioid peptide - and more receptors for pain research. Nat. Neurosci. 5, 185-186 (2002)
95. Stein, C., Millan, M.J., Shippenberg, T.S. & Herz, A. Peripheral effect of fentanyl upon nociception in inflamed tissue of the rat. Neurosci. Lett. 84, 225-228 (1988).
96. Stein, C. et al. Analgesic effect of intraarticular morphine after arthroscopic knee surgery. N. Engl. J. Med. 325, 1123-1126 (1991).
97. Joris, J.L., Dubner, R. & Hargreaves, K.M. Opioid analgesia at peripheral sites: a target for opioids released during stress and inflammation? Anesth. Analg. 66, 1277-1281 (1987).
98. Koppert, W. et al. Peripheral antihyperalgesic effect of morphine to heat, but not mechanical, stimulation in healthy volunteers after ultraviolet-B irradiation. Anesth. Analg. 88, 117-122 (1999).
99. Likar, R., Kapral, S., Steinkellner, H., Stein, C. & Schäfer, M. Dose-dependency of intra-articular morphine analgesia. Br. J. Anaesth. 83, 241-244 (1999).
100. Dionne, R.A. et al. Analgesic effects of peripherally administered opioids in clinical models of acute and chronic inflammation. Clin. Pharmacol. Ther. 70, 66-73 (2001).
101. Moiniche, S., Dahl, J.B. & Kehlet, H. Peripheral antinociceptive effects of morphine after burn injury. Acta Anaesthesiol. Scand. 37, 710-712 (1993).
102. Binder, W., Carmody, J. & Walker, J. Effect of gender on anti-inflammatory and analgesic actions of two kappa-opioids. J. Pharmacol. Exp. Ther. 292, 303-309 (2000).
103. Krajnik, M., Zylicz, Z., Finlay, I., Luczak, J. & van Sorge, A.A. Potential uses of topical epioids in palliative care-report of 6 cases. Pain 80, 121-125 (1999).